Sort   by:  
 Page size 
UnknownClonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
Not available
S-EPMC7979861 | biostudies-literature
UnknownInterplay between whole-genome doubling and the accumulation of deleterious alterations in cancer evolution.
Not available
S-EPMC7116784 | biostudies-literature
UnknownPhase 2b Controlled Trial of M72/AS01<sub>E</sub> Vaccine to Prevent Tuberculosis.
Not available
S-EPMC6151253 | biostudies-literature
UnknownA clonal expression biomarker associates with lung cancer mortality.
Not available
S-EPMC6984959 | biostudies-literature
UnknownNeoantigen-directed immune escape in lung cancer evolution.
Not available
S-EPMC6954100 | biostudies-literature
UnknownAllele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.
Not available
S-EPMC5720478 | biostudies-literature
UnknownPhylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Not available
S-EPMC5812436 | biostudies-literature
UnknownHost-directed therapies for infectious diseases: current status, recent progress, and future prospects.
Not available
S-EPMC7164794 | biostudies-literature
UnknownFc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors.
Not available
S-EPMC5437702 | biostudies-literature
UnknownFc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies.
Not available
S-EPMC5904288 | biostudies-literature
Sort   by:  
 Page size